These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 844227

  • 1. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF, McEnery PT, McAdams AJ, West CD.
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [Abstract] [Full Text] [Related]

  • 2. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y, Vernier RL, Fish AJ, Michael AF.
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [Abstract] [Full Text] [Related]

  • 3. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK, Cavallo T.
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [Abstract] [Full Text] [Related]

  • 4. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
    Strife CF, Jackson EC, McAdams AJ.
    Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
    [Abstract] [Full Text] [Related]

  • 5. Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.
    Mampaso F, Leyva-Cobián F, Martínez-Montero JC, Gonzalo A, Bellas C, Moneo I, Junquera E.
    Clin Nephrol; 1983 Feb; 19(2):92-8. PubMed ID: 6188567
    [Abstract] [Full Text] [Related]

  • 6. Granular dense deposit disease.
    King JT, Valenzuela R, McCormack LJ, Osborne DG.
    Lab Invest; 1978 Dec; 39(6):591-6. PubMed ID: 368430
    [Abstract] [Full Text] [Related]

  • 7. [Membranoproliferative glomerulonephritis. Morphological observations and considerations on pathogenesis].
    Anders D.
    Immun Infekt; 1982 Nov; 10(6):219-29. PubMed ID: 6764212
    [Abstract] [Full Text] [Related]

  • 8. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB, Tarantino A, Bazzi C, Colasanti G, Guerra L, Durante A.
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [Abstract] [Full Text] [Related]

  • 9. The development and resolution of glomerular basement membrane changes associated with subepithelial immune deposits.
    Törnroth T, Skrifvars B.
    Am J Pathol; 1975 May; 79(2):219-36. PubMed ID: 1096633
    [Abstract] [Full Text] [Related]

  • 10. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
    Strife CF, McAdams AJ, West CD.
    Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
    [Abstract] [Full Text] [Related]

  • 11. Glomerular complement components in human glomerulonephritis.
    Verroust PJ, Wilson CB, Cooper NR, Edgington TS, Dixon FJ.
    J Clin Invest; 1974 Jan; 53(1):77-84. PubMed ID: 4586873
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
    Venkataseshan VS, Lieberman K, Kim DU, Thung SN, Dikman S, D'Agati V, Susin M, Valderrama E, Gauthier B, Prakash A.
    Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
    [Abstract] [Full Text] [Related]

  • 13. Basement membrane-changes in membranoproliferative glomerulonephritis: a light and electron microscopic study.
    Anders D, Thoenes W.
    Virchows Arch A Pathol Anat Histol; 1975 Dec 31; 369(2):87-109. PubMed ID: 56082
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemistry of glomerulonephritis.
    Berger J, Yaneva H, Hinglais N.
    Adv Nephrol Necker Hosp; 1971 Dec 31; 1():11-30. PubMed ID: 5006252
    [No Abstract] [Full Text] [Related]

  • 15. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH, Lambert PH, Miescher PA.
    J Clin Invest; 1975 Jul 31; 56(1):165-76. PubMed ID: 1141431
    [Abstract] [Full Text] [Related]

  • 16. Observations on the evolution of idiopathic rapidly progressive glomerulonephritis.
    Davis CA, McEnery PT, Maby S, McAdams AJ, West CD.
    Clin Nephrol; 1978 Mar 31; 9(3):91-101. PubMed ID: 346274
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis.
    West CD.
    Kidney Int; 1976 Jan 31; 9(1):1-7. PubMed ID: 133266
    [No Abstract] [Full Text] [Related]

  • 18. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM, Vallota EH, West CD.
    Kidney Int; 1976 Jan 31; 9(1):46-53. PubMed ID: 781380
    [Abstract] [Full Text] [Related]

  • 19. Histological, ultrastructural and immunofluorescence studies in membranoproliferative glomerulonephritis.
    Nagi AH.
    J Pathol; 1972 Mar 31; 106(3):151-4. PubMed ID: 4114030
    [No Abstract] [Full Text] [Related]

  • 20. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN).
    Levy M, Gubler MC, Sich M, Beziau A, Habib R.
    Clin Immunol Immunopathol; 1978 Aug 31; 10(4):477-92. PubMed ID: 357058
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.